Stimulation of the immune system by different TBE-virus vaccine

International Journal of Medical Microbiology, Supplement

Volumn 293, Issue 37, 2004, Pages 139-144

  Marth, Egon ^a   Kleinhappl, Barbara ^a   Jelovcan, Sandra ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cytokines; Fever; Immune system; In vitro; TBEV vaccines; TNF

Indexed keywords

ALBUMIN; EDETIC ACID; ENCEPUR K; ENCEPUR KINDER; FSME IMMUN; HEPARIN; IMMUNOGLOBULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEW DRUG; POLYGELINE; PROTEIN; STABILIZING AGENT; SUCROSE; THIOMERSAL; TICK BORNE ENCEPHALITIS VACCINE; TICOVAC; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG FORMULATION; EUROPE; EX VIVO STUDY; FEBRILE CONVULSION; FEVER; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; NONHUMAN; PREVALENCE; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS TRANSMISSION;

EID: 3242693525     PISSN: 14331128     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1433-1128(04)80025-1     Document Type: Conference Paper

References (28)

1. Anonymous: FSME-Impfstoff ENCEPUR K vom Markt. Pharm. Z. 143 (15), 1470 (1998).
2. Benda, R., Danes, L.: Evaluation of the immunogenic efficiency of tick-borne encephalitis virus vaccine. In: Biology of viruses of the tick-borne encephalitis complex (Librkova H ed.), pp. 317. Prague, Czechoslovak Academy of Sciences, 1962.
3. Benda, R., Danes, L.: Study of the possibility of preparing a vaccine against tick-borne encephalitis using tissue culture methods. V. Experimental data for the evaluation of the efficiency of formol-treated vaccines in laboratory animals. Acta Virol. 5, 37-49 (1961).
4. Bock, H. L., Klockmann, U., Jüngst, C., Schindel-Künzel, F., Theobald, K., Zerban, R.: A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study. Vaccine 8 (1), 22-24 (1990).
5. Dinarello, C. A.: Proinflammatory cytokines. Chest 118 (2), 503-508 (2000).
6. Girgsdies, O. E., Rosenkranz, G.: Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. Vaccine 14 (15), 1421-1427 (1996).
7. Harabacz, I., Bock, H., Jüngst, C., Klockmann, U., Praus, M., Weber, R.: A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. Vaccine 10 (3), 145-150 (1992).
8. Heinz, F. X., Berger, R., Tuma, W., Kunz, C.: A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology 126, 525-538 (1983).
9. Heinz, F. X., Kunz, C., Fauma, H.: Preparation of a highly purified vaccine against tick-borne encephalitis by continuous low ultracentrifugation. J. Med. Virol. 6, 213-221 (1980).
10. Herman, A., Kappler, J. W., Marrack, P., Pullen, A. M.: Superantigens: mechanism of T cell stimulation and role in immune responses. Annu. Rev. Immunol. 9, 745-772 (1991).
11. Hirano, T.: The biology of interleukin-6. Chem. Immunol. 51, 153-180 (1992)
12. Klockmann, U., Bock, H., Franke, V., Hein, B., Reiner, G., Hilfenhaus, J.: Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine. J. Biol. Stand. 17, 331-342 (1989).
13. Klockmann, U., Bock, H. L., Kwasny, H., Praus, M., Cihlová, V., Tomková, E., Krivanec, K.: Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization. Vaccine 9 (1), 42-46 (1991).
14. Kunz, C., Heinz, F., Hofmann, H.: Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis. J. Med. Virol. 6, 103-109 (1980).
15. Kunz, C.: Die Frühsommer-Meningoenzephalitis. In: Klinische Virologie (Gsell O, Krech U, Mohr W, eds.), pp. 275-285. Munich, Urban und Schwarzenberg, 1986.
16. Kunz, C.: Tick-borne encephalitis in Europe. Acta Leiden 60 (2), 1-14 (1992).
17. Marth, E., Kleinhappl, B.: Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination. Vaccine 20 (3-4), 532-37 (2001).
18. Miethke, T., Duschek, K., Wahl, C., Heeg, K., Wagner, H.: Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur. J. Immunol. 23, 1494-1500 (1993).
19. Parsonnet, J.: Mediators in the pathogenesis of TSS: overview. Rev. Infect. Dis. 11 (Suppl. 1), S263-S269 (1989).
20. Reiser, R. F., Robbins, P. L. N., Nuleto, A. L., Khoe, G. P., Bergdoll, M. S.: Identification, purification, and some physicochemical properties of staphylococcal enterotoxin C3. Infect. Immun. 45, 625-630 (1984).
21. Rosenkranz, G.: Can we reduce the dose of a vaccine? Controlled Clinical Trials 18, 43-53 (1997).
22. Smorodintsev, A. A., Kacan, U. V., Leukavicn, E. N., Dankovskji, N. L.: Experimenteller und epidemiologischer Beitrag zur aktiven Immunisierung gegen die Frühsommer-Meningo-Encephalitis. Arch. Ges. Virusforsch. 3, 1-26 (1941).
23. Suk, K., Erickson, K. L.: Differential regulation of tumour necrosis factor-alpha mRNA degradation in macrophages by interleukin-4 and interferon-gamma. Immunology 87, 551-558 (1996).
24. Tracey, K. J., Cerami, A.: Tumor necrosis factor. A pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503 (1994).
25. WHO: Tick-borne encephalitis and haemorrhagic fever with renal syndrome in Europe. Report on a WHO meeting, Baden, 1983. Euro Reports and Studies, 104 (1986).
26. Zent, O., Arras-Reiter, C., Broecker, M., Hennig, R.: Immediate allergic reactions after vaccination - a post-marketing surveillance review. Eur. J. Pediatr. 161, 21-25 (2002).
27. Zent, O., Banzhoff, A., Hilbert, A. K., Meriste, S., Sluzewski, W., Wittermann, C.: Safety, immunogenicity and tolerability of a new paediatric Tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine (2003) in press.
28. Zhengyin, Y., Yang, D. C. H., Neill, R., Jett, M.: Production of tumour necrosis factor alpha in human T-lymphocytes by staphylococcal enterotoxin B correlates with toxin-induced proliferation and is regulated through protein kinase C. Infect. Immun. 67 (12), 6611-6618 (1999).